We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen’s LDL-Lowering Repatha’s Effective, but Safety Concerns Remain
Amgen’s LDL-Lowering Repatha’s Effective, but Safety Concerns Remain
Amgen’s injectable Repatha proved effective in lowering bad LDL cholesterol in a series of Phase 3 trials, but the FDA says some safety concerns remain.